Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study

• Main Authors: O.M. Moreno-Arrones (Author), S. Béa-Ardebol (Author), F. Mayo-Martinez (Author), G. Pérez-Pastor (Author), I. Torres-Navarro (Author), M. Bonfill-Ortí (Author), G. Deza (Author), V. Ruiz-Salas (Author), E. Masferrer (Author), C. Feal (Author), L. Turrión-Merino (Author), A. Toll (Author), M. Yébenes (Author), S. Galiano-Mejías (Author), A. Jaka (Author), C. Ferrandiz-Pulido (Author), A. Florez (Author), N. Hernández-Hernández (Author), R. Fernández- (Author), L. Rios-Buceta (Author), O. Sanmartin (Author)
• Format: Book
• Published: Elsevier, 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Basal cell carcinoma (BCC) is the most prevalent cancer. A minority of BCCs have an aggressive behaviour (laBCC) and may require hedgehog pathway inhibitors such as sonidegib as its treatment. Objective: To describe the use of sonidegib in a large number of patients and provide more data...